ALNYLAM PHARMACEUTICALS INC's ticker is and the CUSIP is 02043Q957. A total of 5 filers reported holding ALNYLAM PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $559,000 | +46.0% | 10,900 | +78.7% | 0.00% | +100.0% |
Q1 2016 | $383,000 | +40.3% | 6,100 | +110.3% | 0.00% | +100.0% |
Q4 2015 | $273,000 | -67.3% | 2,900 | -72.1% | 0.00% | -66.7% |
Q3 2015 | $836,000 | -50.2% | 10,400 | -25.7% | 0.00% | -62.5% |
Q2 2015 | $1,678,000 | +179.7% | 14,000 | +47.4% | 0.01% | +166.7% |
Q2 2014 | $600,000 | -70.2% | 9,500 | -68.3% | 0.00% | -66.7% |
Q1 2014 | $2,014,000 | +606.7% | 30,000 | +226.1% | 0.01% | +800.0% |
Q2 2013 | $285,000 | – | 9,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SPHERA FUNDS MANAGEMENT LTD. | 600 | $3,329,000 | 0.86% |
SABBY MANAGEMENT, LLC | 606 | $3,363,000 | 0.18% |
GROUP ONE TRADING, L.P. | 60,000 | $3,329,000 | 0.04% |
SIMPLEX TRADING, LLC | 214 | $95,000 | 0.01% |
Citadel Advisors | 16,600 | $921,000 | 0.00% |